ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,076Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 183

$1.64M Total Retail Price of All Prescriptions

Rank: 5 out of 183

750 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 750 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 750 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 5,736 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$181 was the average price of a prescription from this provider, compared to $192 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
DONEPEZIL HCL 553 515 1 4
NAMENDA 514 504 2 5
CARBIDOPA-LEVODOPA 503 449 3 2
TOPIRAMATE 328 80 4 6
GABAPENTIN 328 217 4 1
LEVETIRACETAM 296 94 6 3
PRIMIDONE 244 175 7 8
ROPINIROLE HCL 197 160 8 14
LYRICA 186 70 9 11
DIVALPROEX SODIUM 184 97 10 23
CARBAMAZEPINE 179 66 11 21
TRAMADOL HCL 175 110 12 19
HYDROCODONE-ACETAMINOPHEN 167 79 S3 13 7
SERTRALINE HCL 164 135 14 25
ARICEPT 158 156 15 59
PHENYTOIN SODIUM EXTENDED 155 79 16 13
AGGRENOX 155 145 16 37
CYMBALTA 146 74 18 16
BACLOFEN 134 34 19 15
EXELON 131 125 20 12
ZOLPIDEM TARTRATE 123 73 21 20
LAMOTRIGINE 122 59 22 9
PROPRANOLOL HCL 110 71 23 27
SUMATRIPTAN SUCCINATE 92 0 24 40
CITALOPRAM HBR 83 51 25 17
DIVALPROEX SODIUM ER 82 51 26 26
TIZANIDINE HCL 77 32 27 18
AMITRIPTYLINE HCL 76 17 R 28 10
RIVASTIGMINE 76 63 28 78
TRAZODONE HCL 75 40 30 36
CYCLOBENZAPRINE HCL 74 19 R 31 44
LEVOTHYROXINE SODIUM 70 57 32 60
VENLAFAXINE HCL 70 54 32 129
POTASSIUM CHLORIDE 68 63 34 69
GALANTAMINE HBR 67 67 35 53
BETASERON 66 33 36 105
RISPERIDONE 66 64 36 43
VENLAFAXINE HCL ER 62 38 38 63
DILANTIN 61 35 39 31
IMIPRAMINE HCL 60 27 R 40 137
CLOPIDOGREL 59 47 41 30
QUETIAPINE FUMARATE 58 43 42 29
METHOCARBAMOL 56 18 R 43 92
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.